Connection

LI-YUAN YU-LEE to Osteoblasts

This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Osteoblasts.
Connection Strength

1.503
  1. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF?RIII-p38MAPK-pS249/T252RB Pathway. Cancer Res. 2018 06 01; 78(11):2911-2924.
    View in: PubMed
    Score: 0.500
  2. Bone secreted factors induce cellular quiescence in prostate cancer cells. Sci Rep. 2019 12 09; 9(1):18635.
    View in: PubMed
    Score: 0.141
  3. Osteoblastic Factors in Prostate Cancer Bone Metastasis. Curr Osteoporos Rep. 2018 12; 16(6):642-647.
    View in: PubMed
    Score: 0.132
  4. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 01; 20(1):32-43.
    View in: PubMed
    Score: 0.123
  5. Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells. J Proteome Res. 2017 08 04; 16(8):2709-2728.
    View in: PubMed
    Score: 0.120
  6. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017 06 05; 41(5):467-480.e3.
    View in: PubMed
    Score: 0.119
  7. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010 Jun 01; 70(11):4580-9.
    View in: PubMed
    Score: 0.073
  8. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene. 2010 Jun 03; 29(22):3196-207.
    View in: PubMed
    Score: 0.072
  9. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006 Dec; 25(4):601-9.
    View in: PubMed
    Score: 0.057
  10. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol. 2004 Jun; 203(2):688-95.
    View in: PubMed
    Score: 0.048
  11. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition. Cancer Res. 2022 09 02; 82(17):3158-3171.
    View in: PubMed
    Score: 0.043
  12. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene. 2022 Feb; 41(6):757-769.
    View in: PubMed
    Score: 0.040
  13. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011 Aug 01; 71(15):5194-203.
    View in: PubMed
    Score: 0.020
  14. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 04; 27(39):5195-203.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.